目录
EDITORIAL
- Cancer immunology and immunotherapy
- Single-cell RNA sequencing reveals spatial heterogeneity and immune evasion of circulating tumor cells
- Epithelial cells mimic immune cells: a novel path toward tumor immunotherapy
- The role of DLL1 in long-term vascular normalization and cancer immunotherapy
- Repurposing glucocorticoids as adjuvant reagents for immune checkpoint inhibitors in solid cancers
- Multiplex imaging reveals the architecture of the tumor immune microenvironment
REVIEW
- Personalized immunotherapy in cancer precision medicine
- Cellular immunotherapy for hematological malignancy:recent progress and future perspectives
- Insights into tertiary lymphoid structures in the solid tumor microenvironment: anti-tumor mechanism, functional regulation, and immunotherapeutic strategies
- Targeting myeloid-derived suppressor cells for cancer therapy
ORIGINAL ARTICLE
- EZH2 identifies the precursors of human natural killer cells with trained immunity
- The commensal consortium of the gut microbiome is associated with favorable responses to anti-programmed death protein 1 (PD-1) therapy in thoracic neoplasms
- Residue substitution enhances the immunogenicity of neoepitopes from gastric cancers
- Culturing adequate CAR-T cells from less peripheral blood to treat B-cell malignancies
- Evaluation of 30 DNA damage response and 6 mismatch repair gene mutations as biomarkers for immunotherapy outcomes across multiple solid tumor types
- Synergistic effects of AAGL and anti-PD-1 on hepatocellular carcinoma through lymphocyte recruitment to the liver
- Ferritin as a diagnostic, differential diagnostic, and prognostic marker for immune-related adverse events
- Analysis of characteristics and predictive factors of immune checkpoint inhibitor-related adverse events
- The prognostic landscape of genes and infiltrating immune cells in cytokine induced killer cell treated-lung squamous cell carcinoma and adenocarcinoma